Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Alectinib, a novel alternative anaplastic lymphoma kinase (ALK) inhibitor, is highly effective against ALK-positive non-small cell lung cancer (NSCLC) and is well tolerated. Molecular targeted agents generally have little contribution to alopecia. We encountered a case of alopecia that developed gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Koizumi, Tomonobu, Fukushima, Toshirou, Gomi, Daisuke, Kobayashi, Takashi, Sekiguchi, Nodoka, Sakamoto, Akiyuki, Sasaki, Shigeru, Mamiya, Keiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Published online: April, 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868938/
https://www.ncbi.nlm.nih.gov/pubmed/27194980
http://dx.doi.org/10.1159/000445288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868938/
https://www.ncbi.nlm.nih.gov/pubmed/27194980
http://dx.doi.org/10.1159/000445288

Ejemplares similares